0.1CHF
1.31 MCHF
93.97 MCHF
7.36 M
About COSMO PHARM N
Sector
CEO
Alessandro Della Chà
Headquarters
Dublin
Website
Founded
2016
ISIN
NL0011832936
FIGI
BBG00CWX1FP3
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of COPN is 69.50 CHF — it has decreased by 0.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange COSMO PHARM N stocks are traded under the ticker COPN.
COSMO PHARM N is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for COSMO PHARM N has a max estimate of 110.43 CHF and a min estimate of 79.27 CHF.
Yes, you can track COSMO PHARM N financials in yearly and quarterly reports right on TradingView.
Like other stocks, COPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMO PHARM N stock right from TradingView charts — choose your broker and connect to your account.